Guaifenesin 1200 mg (guaifenesin 1200 mg) Dailymed
Generic: guaifenesin 1200 mg is used for the treatment of Bronchitis Common Cold Cough Laryngitis Pharyngitis Rhinitis, Allergic, Perennial Sinusitis Whooping Cough
IMPRINT: 41
SHAPE: oval
COLOR: blue
All Imprints
guaifenesin 1200 mg - 41 oval blue
guaifenesin 600 mg - 42 oval blue
Go PRO for all pill images
Otc - Active Ingredient Section
For 600 mg:Â Â Â Â Â Â Â Â Â Â Â Active ingredient (in each extended-release tablet)
Guaifenesin, USP 600 mg
For 1200 mg: Active ingredient (in each extended-release tablet)
Guaifenesin, USP 1200 mg
Otc - Purpose Section
Purpose
Expectorant
Indications & Usage Section
Uses
• helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Warnings Section
Otc - Do Not Use Section
Do not use
• for children under 12 years of age
Otc - Ask Doctor Section
Ask a doctor before use if you have
• persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema • cough accompanied by too much phlegm (mucus)
Otc - Stop Use Section
Stop use and ask a doctor if
- cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
Otc - Pregnancy Or Breast Feeding Section
If pregnant or breast-feeding, ask a health professional before use.
Otc - Keep Out Of Reach Of Children Section
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Dosage & Administration Section
Directions
For 600 mg
• do not crush, chew, or break extended - release tablet • take with a full glass of water • this product can be administered without regard for the timing of meals • adults and children 12 years of age and over: 1 or 2 extended - release tablets every 12 hours. Do not exceed 4 extended - release tablets in 24 hours. • children under 12 years of age: do not use
For 1200 mg
• do not crush, chew, or break extended - release tablet • take with a full glass of water • this product can be administered without regard for the timing of meals • adults and children 12 years of age and over: 1 extended - release tablet every 12 hours. Do not exceed 2 extended - release tablets in 24 hours. • children under 12 years of age: do not use
Storage And Handling Section
Other information
• store at 20-25°C (68-77°F)
Inactive Ingredient Section
Inactive ingredients colloidal silicon dioxide, copovidone, FD&C Blue No. 1 Aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone (K-30), sodium starch glycolate, stearic acid
Otc - Questions Section
Questions or comments?
Call 1-877-376-4271 (weekdays 9 AM to 5 PM) You may also report side effects to this phone number.
Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue, Farmingdale, NY 11735, USA
Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83 Verna Indl. Estate Verna, Goa-403722, IndiaÂ
Principal Display Panel
NDC: 25000-042-55
Guaifenesin Extended-Release Tablets 600 mg
20's count (2 x 10's buler) Carton
NDC: 25000-042-01
Guaifenesin Extended-Release Tablets 600 mg
20's count Bottle Label
NDC: 25000-042-01
Guaifenesin Extended-Release Tablets 600 mg
20's count Bottle Carton
NDC: 25000-042-12
Guaifenesin Extended-Release Tablets 600 mg
500's count Bottle Label
NDC: 25000-041-75
Guaifenesin Extended-Release Tablets 1200 mg
12's count (2 x 6's buler) Carton
NDC: 25000-041-12
Guaifenesin Extended-Release Tablets 1200 mg
500's count Bottle Label
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
